![P507 What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?]()
P507 What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?Lefebvre, T; Cormons, R; Faucheron, J -L; Baudrant, M; Bonaz, B; Mathieu, N · Journal of Crohn's and Colitis · 2018